{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:48:29Z","timestamp":1770313709888,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270190"],"award-info":[{"award-number":["82270190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06812-9","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:26:56Z","timestamp":1768526816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of mini-cvd combined with venetoclax and azacitidine in philadelphia chromosome-negative acute leukemia of ambiguous lineage: a single-center retrospective study"],"prefix":"10.1007","volume":"105","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiesi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangsong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"2","key":"6812_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11912-020-01010-w","volume":"23","author":"TB Alexander","year":"2021","unstructured":"Alexander TB, Orgel E (2021) Mixed phenotype acute leukemia: current approaches to diagnosis and treatment. Curr Oncol Rep 23(2):22","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"6812_CR2","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1038\/leu.2010.202","volume":"24","author":"OK Weinberg","year":"2010","unstructured":"Weinberg OK, Arber DA (2010) Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia 24(11):1844\u20131851","journal-title":"Leukemia"},{"key":"6812_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.leukres.2016.04.002","volume":"45","author":"H Tian","year":"2016","unstructured":"Tian H, Xu Y, Liu L, Yan L, Jin Z, Tang X et al (2016) Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone. Leuk Res 45:40\u20136","journal-title":"Leuk Res"},{"issue":"5","key":"6812_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/ejh.12516","volume":"95","author":"H Shimizu","year":"2015","unstructured":"Shimizu H, Saitoh T, Machida S, Kako S, Doki N, Mori T et al (2015) Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis. Eur J Haematol 95(5):455\u201360","journal-title":"Eur J Haematol"},{"issue":"3","key":"6812_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1182\/blood-2017-12-821363","volume":"132","author":"O Hrusak","year":"2018","unstructured":"Hrusak O, de Haas V, Stancikova J, Vakrmanova B, Janotova I, Mejstrikova E et al (2018) International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood 132(3):264\u2013276","journal-title":"Blood"},{"issue":"3","key":"6812_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/cncr.32552","volume":"126","author":"E Orgel","year":"2020","unstructured":"Orgel E, Alexander TB, Wood BL, Kahwash SB, Devidas M, Dai Y et al (2020) Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the children\u2019s oncology group acute leukemia of ambiguous lineage task force. Cancer 126(3):593\u2013601","journal-title":"Cancer"},{"issue":"3","key":"6812_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1182\/bloodadvances.2024014405","volume":"9","author":"MR Luskin","year":"2025","unstructured":"Luskin MR, Shimony S, Keating J, Winer ES, Garcia JS, Stone RM et al (2025) Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia. Blood Adv 9(3):617\u2013626","journal-title":"Blood Adv"},{"issue":"24","key":"6812_CR8","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood.2020004856","volume":"135","author":"AH Wei","year":"2020","unstructured":"Wei AH, Montesinos P, Ivanov V, DiNardo CD, Novak J, Laribi K et al (2020) Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. Blood 135(24):2137\u20132145","journal-title":"Blood"},{"issue":"7","key":"6812_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH et al (2020) Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Engl J Med 383(7):617\u2013629","journal-title":"N Engl J Med"},{"issue":"6","key":"6812_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/bjh.20065","volume":"206","author":"V Agrawal","year":"2025","unstructured":"Agrawal V, Arslan S, Pourhassan H, Koller P, Aldoss I, Pullarkat V (2025) Hypomethylating agent and venetoclax are effective salvage therapies in relapsed\/refractory early T-cell precursor acute lymphoblastic leukaemia. Br J Haematol 206(6):1678\u20131682","journal-title":"Br J Haematol"},{"issue":"1","key":"6812_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40164-021-00239-w","volume":"10","author":"K Liu","year":"2021","unstructured":"Liu K, Li Y, Qiu S, Zhou C, Wei S, Lin D et al (2021) Efficacy of combination of venetoclax with Azacitidine or chemotherapy in refractory\/relapse acute leukemias of ambiguous lineage, not otherwise specified. Exp Hematol Oncol 10(1):46","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"6812_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and Histiocytic\/Dendritic neoplasms. Leukemia 36(7):1703\u20131719","journal-title":"Leukemia"},{"issue":"12","key":"6812_CR13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345\u20131377","journal-title":"Blood"},{"issue":"9","key":"6812_CR14","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00277-020-04179-z","volume":"99","author":"VH Duong","year":"2020","unstructured":"Duong VH, Begna KH, Kashanian S, Sweet K, Wang ES, Caddell R et al (2020) Favorable outcomes of acute leukemias of ambiguous lineage treated with hyperCVAD: a multi-center retrospective study. Ann Hematol 99(9):2119\u201324","journal-title":"Ann Hematol"},{"key":"6812_CR15","doi-asserted-by":"publisher","first-page":"1395992","DOI":"10.3389\/fonc.2024.1395992","volume":"14","author":"M Karasek","year":"2024","unstructured":"Karasek M, Armatys A, Skarupski M, Bo\u0142kun \u0141, Budziszewska K, Drozd-Soko\u0142owska J et al (2024) A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience. Front Oncol 14:1395992","journal-title":"Front Oncol"},{"issue":"4","key":"6812_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1080\/10428194.2024.2443017","volume":"66","author":"S Tessier","year":"2025","unstructured":"Tessier S, McCullough KB, Gangat N, Begna KH, Saliba AN, Mangoankar AA et al (2025) Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and Idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia. Leuk Lymphoma 66(4):780\u2013784","journal-title":"Leuk Lymphoma"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06812-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:33:48Z","timestamp":1770262428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06812-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6812"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06812-9","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the Helsinki Declaration 2013. Written informed consent was obtained from the patients or patients\u2019 arents\/legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}